comparemela.com

Latest Breaking News On - Lava therapeuticsnv stock exchange - Page 1 : comparemela.com

LAVA Therapeutics N : Consolidated Financial Statements - Form 6-K

Table of Contents Exhibit 99.1 LAVA THERAPEUTICS N.V. INDEX TO UNAUDITED. | June 8, 2023

United statesStichting vumcDutch researchInternational financial reporting standardsInternational accounting standards boardDevelopment actSeagen incInternational accounting standardExchange commissionSeagen agreement the companyJanssen biotech incDevelopment expensesConsolidated interim statementsMonths ended marchNasdaq global selectAudit committee

LAVA Therapeutics to Participate in the Jefferies Healthcare Conference

UTRECHT, The Netherlands and PHILADELPHIA, June 01, 2023 LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific. | June 1, 2023

United statesStephen hurlyJefferies healthcareFireside chatLava therapeuticsnv stock exchangePress releaseF lvtx nl0015000ag6

LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development

Through a research collaboration with Janssen, a lead candidate was identified for further development towards clinical studies.In May 2020, LAVA entered into a research collaboration and license. | June 1, 2023

United statesJanssen pharmaceutical companies of johnsonExchange commissionJanssen biotech incJanssen biotechJanssen pharmaceutical companiesStephen hurlyLava therapeuticsnv stock exchangePress releaseNd lvtx nl0015000ag6

LAVA Therapeutics Announces the Appointment of Dr Charles Morris as Chief Medical Officer

UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific. | February 6, 2023

United kingdomUnited statesCity ofBenjamin winogradCharles morrisAllos therapeuticsRadius healthSheffield university medical schoolStephen hurlyCelyad oncologyPsioxus therapeuticsMedical scienceClinical pharmacologyRoyal collegeLava therapeuticsnv stock exchangePress release

vimarsana © 2020. All Rights Reserved.